Soleno drops as patient on Vykat XR dies (SLNO:NASDAQ)

Core Insights - Shares of Soleno Therapeutics (NASDAQ:SLNO) experienced a decline following the report of a death of a 17-year-old male patient who was treated with the company's recently launched rare disease therapy, Vykat XR [3] Company Summary - Soleno Therapeutics is a biotech company based in Redwood City, California, which recently launched a therapy for rare diseases [3]